Raiffeisen Bank International AG Boosts Stock Holdings in Veeva Systems Inc. $VEEV

Raiffeisen Bank International AG lifted its position in Veeva Systems Inc. (NYSE:VEEV) by 2,790.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,480 shares of the technology company’s stock after acquiring an additional 4,325 shares during the quarter. Raiffeisen Bank International AG’s holdings in Veeva Systems were worth $789,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. SHP Wealth Management bought a new position in shares of Veeva Systems in the fourth quarter valued at approximately $26,000. Arlington Trust Co LLC bought a new stake in Veeva Systems during the second quarter worth $29,000. Field & Main Bank bought a new stake in Veeva Systems during the second quarter worth $29,000. MV Capital Management Inc. purchased a new position in Veeva Systems in the fourth quarter worth $30,000. Finally, Reflection Asset Management purchased a new position in Veeva Systems in the fourth quarter worth $32,000. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Veeva Systems Trading Down 3.6%

VEEV stock opened at $274.02 on Friday. The firm has a 50 day moving average of $220.49 and a 200-day moving average of $187.95. The firm has a market capitalization of $44.51 billion, a P/E ratio of 45.07, a price-to-earnings-growth ratio of 1.17 and a beta of 0.97. Veeva Systems Inc. has a 12 month low of $148.05 and a 12 month high of $310.50.

Veeva Systems (NYSE:VEEV) last released its quarterly earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share for the quarter, topping the consensus estimate of $2.23 by $0.12. The firm had revenue of $927.96 million for the quarter, compared to analysts’ expectations of $905.38 million. Veeva Systems had a net margin of 29.34% and a return on equity of 14.25%. The business’s quarterly revenue was up 17.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.99 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. Sell-side analysts predict that Veeva Systems Inc. will post 6.7 EPS for the current year.

Analyst Upgrades and Downgrades

VEEV has been the subject of several research analyst reports. Morgan Stanley raised their target price on Veeva Systems from $215.00 to $275.00 and gave the company an “equal weight” rating in a research report on Thursday, August 27th. Wells Fargo & Company boosted their price target on shares of Veeva Systems from $317.00 to $320.00 and gave the stock an “overweight” rating in a report on Thursday, June 4th. BTIG Research restated a “buy” rating and set a $340.00 price target on shares of Veeva Systems in a research report on Thursday, June 4th. Jefferies Financial Group restated a “buy” rating and set a $295.00 price objective on shares of Veeva Systems in a report on Thursday, August 27th. Finally, Wall Street Zen lowered shares of Veeva Systems from a “buy” rating to a “hold” rating in a research report on Monday, August 3rd. Nineteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $284.46.

More Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Higher outlook and strong operating momentum: Veeva raised its fiscal 2027 outlook as Vault CRM migrations, research-and-development investment and Falcon AI adoption support revenue growth and expanding profitability. This follows a strong latest quarter, in which revenue increased 17.6% year over year to approximately $928 million and adjusted earnings exceeded analyst expectations. VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate Fast
• Positive Sentiment: AI adoption is broadening: Regeneron and Biogen have adopted Veeva’s AI-powered Vault CRM suite globally. Veeva also introduced Falcon Safety, an agentic AI product designed for biopharmaceutical safety operations. These developments could deepen customer relationships and expand Veeva’s role in commercial and safety workflows. Why Is Veeva Systems Winning Big in AI For Biopharma?
• Positive Sentiment: Long-term investor support: Commentary highlights Veeva’s recurring-revenue model, Vault CRM migration opportunity and AI expansion as reasons the stock remains attractive for long-term growth investors. Investor Michael Burry has also reportedly remained bullish on Veeva while criticizing Snowflake’s valuation. Burry Remains Bullish on Veeva
• Neutral Sentiment: Valuation and competition remain important considerations: Analysts and portfolio commentary generally support holding VEEV, but warn that market saturation could limit future growth. With the stock trading at a premium earnings multiple after a substantial rally, investors may require continued execution and strong guidance upgrades. Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
• Negative Sentiment: Insider selling may weigh modestly on sentiment: Veeva’s exiting president sold 10,000 shares for approximately $2.8 million, representing about 51% of the executive’s direct equity stake before the transaction. The sale does not establish a change in business fundamentals, but it can raise caution after the stock’s strong advance. Veeva’s Exiting President Sold $2.8 Million in Stock

Insider Activity at Veeva Systems

In other news, insider Thomas Schwenger sold 36,000 shares of the business’s stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $250.23, for a total transaction of $9,008,280.00. Following the completion of the transaction, the insider owned 19,449 shares of the company’s stock, valued at approximately $4,866,723.27. The trade was a 64.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 10.60% of the company’s stock.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.